Mass gainer protein powders, also called weight gain protein powders, are specifically formulated for athletes and weightlifters looking to pack on pounds — particularly lean muscle mass.

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

Despite these benefits, inhalation drug delivery systems are still in the developmental stage, particularly for targeted local delivery. Dry powder inhalers (DPIs) have emerged as a popular choice due ...

It all starts with creating the powder, a process that dates back to 12th-century Japan. (The overall technique of drying, pulverizing, and then mixing whole tea leaves into water to drink dates ...

Britain’s National Institute for Health and Care Excellence said the blue salbutamol inhalers, which in Australia are sold over the counter under the brand name Ventolin, only relieved the ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Those who want to help reduce the carbon footprint will be advised to switch to gasless, dry powder inhalers. Asthma is a common condition that affects 5.4 million people in the UK and causes ...

The carbon footprint of blue inhalers is being compared to a lengthy car trip in advice released to asthma patients as British doctors are told to switch out the sprays for a more effective treatment.

At the governing body's annual Seminar in Nice, France, the UCI also warned teams about the dangers of carbon monoxide inhalation and requested riders and teams not to use "repeated inhalation" of ...

A vegan protein powder may help. Our dietitians vetted more than a dozen plant-based protein powders, while our tester weighed in on flavor. Here are the ones they recommend. Prices for vegan ...

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly ...

The acquisition is set to add Kate Therapeutics’ preclinical candidates for DMD, FSHD and DM1 to Novartis’ portfolio. Credit: © 2024 Novartis AG. Novartis has ...